150 related articles for article (PubMed ID: 32602121)
21. Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient.
Stokes MB; Jagirdar J; Burchstin O; Kornacki S; Kumar A; Gallo G
Mod Pathol; 1997 Oct; 10(10):1059-65. PubMed ID: 9346188
[TBL] [Abstract][Full Text] [Related]
22. The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis.
Czyżewska E; Wiśniewska A; Waszczuk-Gajda A; Ciepiela O
J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33803904
[TBL] [Abstract][Full Text] [Related]
23. Light Chain Amyloidosis (AL) Associated With B Cell Lymphoma a Single Center Experience.
la Torre A; Reece D; Crump M; Atenafu EG; Chen C; Prica A; Kukreti V
Clin Lymphoma Myeloma Leuk; 2021 Dec; 21(12):e946-e959. PubMed ID: 34384733
[TBL] [Abstract][Full Text] [Related]
24. Natural history and outcomes in localised immunoglobulin light-chain amyloidosis: a long-term observational study.
Mahmood S; Bridoux F; Venner CP; Sachchithanantham S; Gilbertson JA; Rowczenio D; Wagner T; Sayed R; Patel K; Fontana M; Whelan CJ; Lachmann HJ; Hawkins PN; Gillmore JD; Wechalekar AD
Lancet Haematol; 2015 Jun; 2(6):e241-50. PubMed ID: 26688234
[TBL] [Abstract][Full Text] [Related]
25. The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment.
Muchtar E; Jevremovic D; Dispenzieri A; Dingli D; Buadi FK; Lacy MQ; Gonsalves W; Hayman SR; Kapoor P; Leung N; Russell S; Lust JA; Lin Y; Go RS; Chakraborty R; Zeldenrust S; Kumar SK; Kyle RA; Rajkumar SV; Gertz MA
Blood; 2017 Jan; 129(1):82-87. PubMed ID: 27729322
[TBL] [Abstract][Full Text] [Related]
26. AL amyloidosis: The effect of fluorescent in situ hybridization abnormalities on organ involvement and survival.
Ozga M; Zhao Q; Benson D; Elder P; Williams N; Bumma N; Rosko A; Chaudhry M; Khan A; Devarakonda S; Kahwash R; Vallakati A; Campbell C; Parikh SV; Almaani S; Prosek J; Bittengle J; Pfund K; LoRusso S; Freimer M; Redder E; Efebera Y; Sharma N
Cancer Med; 2021 Feb; 10(3):965-973. PubMed ID: 33347707
[TBL] [Abstract][Full Text] [Related]
27. Doxycycline Combined With Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Cardiac Light-Chain Amyloidosis: A Multicenter Randomized Controlled Trial.
Shen KN; Fu WJ; Wu Y; Dong YJ; Huang ZX; Wei YQ; Li CR; Sun CY; Chen Y; Miao HL; Zhang YL; Cao XX; Zhou DB; Li J
Circulation; 2022 Jan; 145(1):8-17. PubMed ID: 34503349
[TBL] [Abstract][Full Text] [Related]
28. Nodular amyloidosis: review and long-term follow-up of 16 cases.
Moon AO; Calamia KT; Walsh JS
Arch Dermatol; 2003 Sep; 139(9):1157-9. PubMed ID: 12975157
[TBL] [Abstract][Full Text] [Related]
29. Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases.
Gouvêa AF; Ribeiro AC; León JE; Carlos R; de Almeida OP; Lopes MA
J Oral Pathol Med; 2012 Feb; 41(2):178-85. PubMed ID: 21883489
[TBL] [Abstract][Full Text] [Related]
30. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients.
Comenzo RL; Vosburgh E; Falk RH; Sanchorawala V; Reisinger J; Dubrey S; Dember LM; Berk JL; Akpek G; LaValley M; O'hara C; Arkin CF; Wright DG; Skinner M
Blood; 1998 May; 91(10):3662-70. PubMed ID: 9573002
[TBL] [Abstract][Full Text] [Related]
31. [The prognostic value of baseline serum free light chain in immunoglobulin light-chain cardiac amyloidosis].
Wang LM; Wang TT; Tian Y; Zhao L; Yang XC; Chen WM
Zhonghua Xue Ye Xue Za Zhi; 2020 Jan; 41(1):47-53. PubMed ID: 32023754
[No Abstract] [Full Text] [Related]
32. Fixed duration
Rivera Duarte A; Reece D; Li X; Xu W; Paul H; Masih-Khan E; Winter A; Tiedemann R; Prica A; Chen C; Trudel S; Kukreti V
Amyloid; 2022 Mar; 29(1):23-30. PubMed ID: 34519603
[TBL] [Abstract][Full Text] [Related]
33. [Light chain amyloidosis].
Hegenbart U; Aus dem Siepen F; Schönland S
Inn Med (Heidelb); 2023 Sep; 64(9):842-847. PubMed ID: 37540260
[TBL] [Abstract][Full Text] [Related]
34. Localized AL amyloidosis: a suicidal neoplasm?
Westermark P
Ups J Med Sci; 2012 May; 117(2):244-50. PubMed ID: 22335280
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved.
Al Saleh AS; Sidiqi MH; Muchtar E; Dispenzieri A; Buadi FK; Dingli D; Lacy MQ; Warsame RM; Gonsalves WI; Kourelis TV; Hogan WJ; Hayman SR; Kapoor P; Kumar SK; Gertz MA
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1520-1525. PubMed ID: 31054986
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow plasma cell infiltration in light chain amyloidosis: impact on organ involvement and outcome.
Tovar N; Rodríguez-Lobato LG; Cibeira MT; Magnano L; Isola I; Rosiñol L; Bladé J; Fernández de Larrea C
Amyloid; 2018 Jun; 25(2):79-85. PubMed ID: 29482381
[TBL] [Abstract][Full Text] [Related]
37. The pattern of amyloid deposition in the lung.
Looi LM
Malays J Pathol; 1999 Jun; 21(1):29-35. PubMed ID: 10879276
[TBL] [Abstract][Full Text] [Related]
38. Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis.
Sidiqi MH; Buadi FK; Dispenzieri A; Warsame R; Lacy MQ; Dingli D; Leung N; Gonsalves WI; Kapoor P; Kourelis TV; Hogan WJ; Kumar SK; Gertz MA
Biol Blood Marrow Transplant; 2019 Mar; 25(3):e108-e111. PubMed ID: 30529461
[TBL] [Abstract][Full Text] [Related]
39. Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
Kastritis E; Palladini G; Minnema MC; Wechalekar AD; Jaccard A; Lee HC; Sanchorawala V; Gibbs S; Mollee P; Venner CP; Lu J; Schönland S; Gatt ME; Suzuki K; Kim K; Cibeira MT; Beksac M; Libby E; Valent J; Hungria V; Wong SW; Rosenzweig M; Bumma N; Huart A; Dimopoulos MA; Bhutani D; Waxman AJ; Goodman SA; Zonder JA; Lam S; Song K; Hansen T; Manier S; Roeloffzen W; Jamroziak K; Kwok F; Shimazaki C; Kim JS; Crusoe E; Ahmadi T; Tran N; Qin X; Vasey SY; Tromp B; Schecter JM; Weiss BM; Zhuang SH; Vermeulen J; Merlini G; Comenzo RL;
N Engl J Med; 2021 Jul; 385(1):46-58. PubMed ID: 34192431
[TBL] [Abstract][Full Text] [Related]
40. Localized light chain amyloidosis: A self-limited plasmacytic B-cell lymphoproliferative disorder.
Martínez JC; Lichtman EI
Front Oncol; 2022; 12():1002253. PubMed ID: 36457485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
